학술논문
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates.
Document Type
Article
Author
Brahmer, Julie R.; Drake, Charles G.; Wollner, Ira; Powderly, John D.; Picus, Joel; Sharfman, William H.; Stankevich, Elizabeth; Pons, Alice; Salay, Theresa M.; McMiller, Tracee L.; Gilson, Marta M.; Wang, Changyu; Selby, Mark; Taube, Janis M.; Anders, Robert; Chen, Lieping; Korman, Alan J.; Pardoll, Drew M.; Lowy, Israel; Topalian, Suzanne L.
Source
Journal of Clinical Oncology; 2/1/2023, Vol. 41 Issue 4, p715-723, 9p
Subject
Language
ISSN
0732183X